DK1933829T3 - Fremgangsmåde til bekæmpelse af infektion - Google Patents
Fremgangsmåde til bekæmpelse af infektionInfo
- Publication number
- DK1933829T3 DK1933829T3 DK06779273T DK06779273T DK1933829T3 DK 1933829 T3 DK1933829 T3 DK 1933829T3 DK 06779273 T DK06779273 T DK 06779273T DK 06779273 T DK06779273 T DK 06779273T DK 1933829 T3 DK1933829 T3 DK 1933829T3
- Authority
- DK
- Denmark
- Prior art keywords
- combating infection
- combating
- infection
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/396—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0517957.7A GB0517957D0 (en) | 2005-09-03 | 2005-09-03 | Method of combating infection |
| PCT/GB2006/003252 WO2007026166A2 (fr) | 2005-09-03 | 2006-09-04 | Methode permettant de combattre une infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1933829T3 true DK1933829T3 (da) | 2009-11-30 |
Family
ID=35220805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06779273T DK1933829T3 (da) | 2005-09-03 | 2006-09-04 | Fremgangsmåde til bekæmpelse af infektion |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8415334B2 (fr) |
| EP (1) | EP1933829B1 (fr) |
| CN (1) | CN101282723B (fr) |
| AR (1) | AR055409A1 (fr) |
| AT (1) | ATE437638T1 (fr) |
| BR (1) | BRPI0615448A2 (fr) |
| CA (1) | CA2620398C (fr) |
| CY (1) | CY1109549T1 (fr) |
| DE (1) | DE602006008162D1 (fr) |
| DK (1) | DK1933829T3 (fr) |
| EC (1) | ECSP088328A (fr) |
| ES (1) | ES2356330T3 (fr) |
| GB (1) | GB0517957D0 (fr) |
| MY (1) | MY144154A (fr) |
| PL (1) | PL1933829T3 (fr) |
| PT (1) | PT1933829E (fr) |
| WO (1) | WO2007026166A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0526552D0 (en) | 2005-12-29 | 2006-02-08 | Morvus Technology Ltd | New use |
| GB2442202A (en) | 2006-09-30 | 2008-04-02 | Morvus Technology Ltd | Vermin poison |
| US9173898B2 (en) | 2010-10-12 | 2015-11-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating giardiasis |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3208999A (en) * | 1964-09-09 | 1965-09-28 | Nat Starch Chem Corp | Preparation of non-inhibited starch amines |
| US3658788A (en) * | 1969-06-06 | 1972-04-25 | Salk Inst For Biological Studi | Aminooxazolines and products thereof and processes for synthesizing same |
| CA1089763A (fr) * | 1978-10-30 | 1980-11-18 | Willard J. Johnson | Rodenticide contenant du 6-aminonicotinamide et de l'acide 6-aminonicotinohydroxamique |
| CS204501B1 (en) | 1978-11-06 | 1981-04-30 | Miroslav Dub | Shaped trap for regulation of the numbers of exoantropous and hemisynantropous rodents classes |
| US4375394A (en) * | 1982-03-11 | 1983-03-01 | Eastman Kodak Company | Electrolytic process for the preparation of ethylene glycol and glycerine |
| GB8705477D0 (en) | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
| GB8804068D0 (en) | 1988-02-22 | 1988-03-23 | Roberts J R | Improvements relating to control of neoplastic tissue growth |
| CH680180B5 (fr) * | 1988-07-29 | 1993-01-15 | Ciba Geigy Ag | |
| DE3833194A1 (de) | 1988-09-30 | 1990-04-05 | Basf Ag | Verfahren zum faerben von textilen materialien aus cellulosefasern |
| DE4103639A1 (de) | 1991-02-07 | 1992-08-13 | Basf Ag | Verfahren zum faerben von textilen materialien aus cellulosefasern |
| EP0540263A1 (fr) * | 1991-10-23 | 1993-05-05 | Cancer Research Campaign Technology Limited | Nitroréductase bactérienne pour la réduction de CB 1954 et analogues à une forme cytotoxique |
| GB9412394D0 (en) | 1994-06-21 | 1994-08-10 | Danbiosyst Uk | Colonic drug delivery composition |
| DE4425436A1 (de) * | 1994-07-19 | 1996-01-25 | Basf Ag | Verfahren zur Herstellung von Acyloinen |
| GB9415167D0 (en) | 1994-07-27 | 1994-09-14 | Springer Caroline J | Improvements relating to cancer therapy |
| US5632782A (en) * | 1994-09-01 | 1997-05-27 | Clariant Finance (Bvi) Ltd. | Exhaust dyeing process for sulphur dyes |
| US20040053208A1 (en) | 1995-08-29 | 2004-03-18 | V. I. TECHNOLOGIES, Inc. | Methods to selectively inactivate parasites in biological compositions |
| AU1166097A (en) | 1995-12-21 | 1997-07-17 | British Technology Group Limited | Indoloquinone derivatives as bioreductive agents |
| ATE247984T1 (de) | 1997-02-11 | 2003-09-15 | Univ Manchester | Bioreduktive konjugate zur gezielten wirkstoffzufuhr |
| GB9710699D0 (en) | 1997-05-24 | 1997-07-16 | Danbiosyst Uk | Gastro-retentive controlled release system |
| GB9712370D0 (en) | 1997-06-14 | 1997-08-13 | Aepact Ltd | Therapeutic systems |
| GB2365338B (en) | 1997-06-14 | 2002-04-03 | Enzacta R & D Ltd | Therapeutic systems |
| US6159706A (en) | 1997-12-23 | 2000-12-12 | Newbiotics, Inc. | Application of enzyme prodrugs as anti-infective agents |
| CA2332806A1 (fr) | 1998-05-22 | 1999-12-02 | Natalie Dales | Agents cytotoxiques bioreducteurs |
| WO2000010611A2 (fr) | 1998-08-19 | 2000-03-02 | The Victoria University Of Manchester | Ciblage de medicaments |
| MXPA02008637A (es) | 2000-03-02 | 2004-09-06 | Ml Lab Plc | Elemento de respuesta a factor de celulas t. |
| DE10049468A1 (de) | 2000-10-06 | 2002-04-11 | Bayer Ag | N-Alkoxyalkyl-substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen |
| US20030228285A1 (en) * | 2002-05-03 | 2003-12-11 | Mien-Chie Hung | Bipartite T-cell factor (Tcf)-responsive promoter |
| GB0223696D0 (en) | 2002-10-14 | 2002-11-20 | Ml Lab Plc | Improved immunotherapy |
| CA2570245A1 (fr) | 2004-07-02 | 2006-01-12 | Warner-Lambert Company Llc | Compositions et methodes de traitement d'infections pathologiques |
-
2005
- 2005-09-03 GB GBGB0517957.7A patent/GB0517957D0/en not_active Ceased
-
2006
- 2006-09-01 AR ARP060103838A patent/AR055409A1/es not_active Application Discontinuation
- 2006-09-04 BR BRPI0615448-4A patent/BRPI0615448A2/pt not_active IP Right Cessation
- 2006-09-04 CN CN2006800321523A patent/CN101282723B/zh not_active Expired - Fee Related
- 2006-09-04 MY MYPI20080403A patent/MY144154A/en unknown
- 2006-09-04 AT AT06779273T patent/ATE437638T1/de active
- 2006-09-04 DK DK06779273T patent/DK1933829T3/da active
- 2006-09-04 DE DE602006008162T patent/DE602006008162D1/de active Active
- 2006-09-04 WO PCT/GB2006/003252 patent/WO2007026166A2/fr active Application Filing
- 2006-09-04 PL PL06779273T patent/PL1933829T3/pl unknown
- 2006-09-04 PT PT06779273T patent/PT1933829E/pt unknown
- 2006-09-04 ES ES06779273T patent/ES2356330T3/es active Active
- 2006-09-04 EP EP06779273A patent/EP1933829B1/fr active Active
- 2006-09-04 CA CA2620398A patent/CA2620398C/fr not_active Expired - Fee Related
- 2006-09-04 US US11/991,080 patent/US8415334B2/en not_active Expired - Fee Related
-
2008
- 2008-03-28 EC EC2008008328A patent/ECSP088328A/es unknown
-
2009
- 2009-10-29 CY CY20091101129T patent/CY1109549T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007026166A2 (fr) | 2007-03-08 |
| EP1933829A2 (fr) | 2008-06-25 |
| EP1933829B1 (fr) | 2009-07-29 |
| CA2620398C (fr) | 2010-11-30 |
| DE602006008162D1 (de) | 2009-09-10 |
| CY1109549T1 (el) | 2014-08-13 |
| AR055409A1 (es) | 2007-08-22 |
| CN101282723A (zh) | 2008-10-08 |
| ATE437638T1 (de) | 2009-08-15 |
| WO2007026166A3 (fr) | 2007-06-28 |
| CA2620398A1 (fr) | 2007-03-08 |
| MY144154A (en) | 2011-08-15 |
| US20100273762A1 (en) | 2010-10-28 |
| CN101282723B (zh) | 2012-06-13 |
| PT1933829E (pt) | 2009-11-04 |
| GB0517957D0 (en) | 2005-10-12 |
| US8415334B2 (en) | 2013-04-09 |
| PL1933829T3 (pl) | 2010-01-29 |
| ES2356330T3 (es) | 2011-04-07 |
| ECSP088328A (es) | 2008-08-29 |
| BRPI0615448A2 (pt) | 2011-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022001I2 (el) | Παραγωγα του uk-2a | |
| DK1931350T3 (da) | Administration af inhibitorer af dipeptidylpeptidase | |
| DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
| DK1919904T3 (da) | Makrocykliske inhibitorer af hepatitis-c-virus | |
| DK1962830T3 (da) | Azaindolhæmmere af aurorakinaser. | |
| DK1737461T3 (da) | Carbolin-derivater til inhibering af angiogenese | |
| DK1732604T3 (da) | Fremgangsmåder til behandling af hiv-infektion | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK1877232T3 (da) | Fremgangsmåde til behandling af træoverflader | |
| DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
| DK1896065T3 (da) | Fremgangsmåde til fremstilling af vacciner | |
| DK1720866T3 (da) | Fremgangsmåde | |
| DK1940839T3 (da) | Pyridopyrimidione Inhibitors of P13Ka | |
| DK1755661T3 (da) | Gelsolin til anvendelse til behandling af infektioner | |
| DK1981859T3 (da) | Fremstilling af delmopinol | |
| DK1879844T3 (da) | Fremstilling af natriumdiformiat | |
| DK1917253T3 (da) | Fremgangsmåde til fremstilling af betamimetika | |
| DK1942967T3 (da) | Fremgangsmåde til dosering af medikamenter | |
| NO20055643D0 (no) | Preparation of lodixanol | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| DK1740534T3 (da) | Fremgangsmåde til rensning af mesotrion | |
| DK1812002T3 (da) | Behandling af mastitis | |
| DK1912476T3 (da) | Fremgangsmåde til træning af høreevne | |
| DK1856035T3 (da) | Fremgangsmåde til fremstilling af beskyttelse amidiner |